None listed
Conditions
Brief summary
Previously, the incidence of erectile dysfunction has been shown to be increased in patients having metabolic syndrome (MS). Nonalcoholic steatohepatitis (NASH) is a clinical entity which was advocated as the liver manifestation of MS. We aim to screen the male NASH patients with regard to erectile dysfunction using the 5 point International Index of Erectile Function (IIEF-5) questionnaire. Our secondary end point is to evaluate the demographic findings of NASH patients and test the association of erectile dysfunction with the components of MS. Our secondary end point is to evaluate the demographic findings of NASH patients and test the assciation of erectile dysfunction with the components of MS.
Interventions
We aim to observe the infertility or erectile dysfunction status in NASH patients. Since most NASH patients have accompanying metabolic syndrome we also aim to see how many NASH patients having metabolic syndrome have also high erectile dysfunction. Participants are assessed on one occasion only over a period of about 1 hour via the International Index of Erectile Function 5 point questionnaire.
Sponsors
Marmara University Faculty of Medicine
Eligibility
Sex/Gender
Male
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
Male patients with Nonalcoholic steatohepatitis.
Exclusion criteria
Female patients Patients who have overt diabetes that use oral antidiabetic agents or insulin Patients using antihyperlipidemic agents, antihypertensives, testesteron derivatives Chronic liver disease due to the causes other than Nonalcoholic steatohepatitis, such as chronic hepatitis B, C, alcohol, hemachromatosis, Wilson's disease Diagnosed malignant disease
Outcome results
None listed